← Research library

Original Cyclontane / ADK-638 patent trail

Patent disclosure · 2003

What the patent describes
Original Cyclontane/ADK-638 animal pharmacology, including treadmill groups of 8 preselected rats.
What the source reports
The later patent cites this earlier Cyclontane development record. Original behavioral and toxicity comparisons require direct verification before numerical claims are reproduced.

Reported patent results

Findings described in words

The patent reports increased running-to-exhaustion performance and stimulant-related behavioral effects.

Original Cyclontane/ADK-638 animal pharmacology, including treadmill groups of 8 preselected rats.

Population or model Original Cyclontane/ADK-638 animal pharmacology, including treadmill groups of 8 preselected rats.

Results · Treadmill and anti-catalepsy experiments, Tables 5–6 narrative.
MeasureResultComparison, timing and statistics
Treadmill performanceSignificantly longer running-to-exhaustion at selected tested exposures8 rats per group; exact table means not transcribed
Behavioral pharmacologyAnti-cataleptic activity and stimulant-like responses describedModel-specific comparisons do not establish human superiority to Bromantane

Preselected animal performance is not a human occupational outcome, and the patent’s clinical recommendations exceed the experiments. Findings belong to ADK-638 rather than every related cage compound.

Source for these results ↗ · Reviewed 2026-11-06

Patent claims and provenance

Molecule. Cyclontane development patent; the compound identity is distinct from related cage amides and comparator agents.

A patent disclosure is not clinical proof, marketing approval or a legal opinion. Related publications and patent family members may describe the same experiments.

Publication
RU2196575C2 ↗ · 2003-01-20
Earliest priority / filing
1999-07-30 / 1999-07-30
Original applicant / assignee
Научно-исследовательский институт фармакологии РАМН
Indexed status
Not shown; official status unverified · checked 2026-11-06
Patent family
20223238 · family publications are related filings, not independent studies.
Original title, inventors and related publications

Substance eliciting psychostimulating and antiasthenic effect

Inventors: С.Б. Середенин; И.С. Морозов; Г.Г. Незнамов; Н.В. Климова; Н.И. Авдюнина; И.А. Иванова; С.А. Сергеева; Г.И. Ковалев; Б.М. Пятин; Е.А. Вальдман; О.А. Михайлова; Н.А. Кисляк; О.В. Щербакова; О.Б. Степаненко; Е.А. Цветкова.

RU2196575C2

Original patent PDF ↗

Patent collection and status interpretation →

Study limitations and source details

Study limitations

  • Bibliographic lead only; neither potency ratios nor toxicity estimates from secondary accounts are treated as verified here.

Source details

Prior-art citation followed from the 2018 patent; original retrieval unsuccessful.

Selected reported results and source limitations reviewed; not a complete risk-of-bias or experimental audit.

Sources checked

Citation

Patent / reported experimentsBibliographic record

Author unconfirmed. Original Cyclontane / ADK-638 patent trail RU2196575C2; cited in later RU2674342C2

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards